Skip to main content
Fig. 2 | BMC Neurology

Fig. 2

From: Successful treatment with efgartigimod as an add-on therapy for acute attack of anti-NMDA receptor encephalitis: a case report

Fig. 2

Changes in serum NMDAR antibodies (NMDARAb) and Immunoglobulin G (IgG) levels. The continuous test results for serum NMDARAb demonstrate a decrease in titer and subsequent stabilization following the administration of efgartigimod. The titer further decreases after re-administration of efgartigimod. Additionally, the serum IgG and the CSF NMDARAb indicate a sustained decrease in titer post-efgartigimod treatment

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us